Background: Complications of prostate cancer treatments have a substantial impact on the patient’s quality of life. We evaluated the prevalence of urinary consequences and factors affecting patient satisfaction and decisional regret after treatment. Methods: A retrospective self-administered questionnaire was sent to all members of the National Association of Prostate Cancer Patients in France. Results: From the 226 completed questionnaires received, the following information was obtained: 110 patients underwent surgery only, 29 received radiotherapy plus hormone therapy, 28 received radiotherapy only, and 49 received other combination treatments. The median follow-up period was 58.1 months. After treatment, the presence of urinary incontinence was reported by 34.5% of patients treated by radical prostatectomy, by 10.3% treated by radiotherapy plus hormone therapy, by 17.8% treated by curitherapy or radiotherapy only, and by 38.7% treated by other combination therapy (p = 0.01). The main reasons for decisional regret were the fact that patients received incomplete information about prostate cancer (40%) and consequences of treatment that affected the urinary system (34%). The information received about cancer was considered complete in 32.3% of the satisfied group and 14.3% of the decisional regret group (p = 0.003) and with regard to urinary incontinence the information received was considered complete in 41.4 and 17.4% respectively (p < 0.01). Conclusions: Urinary consequences of prostate cancer treatment are common and impact the quality of life. Patients need clear information to be able to participate in therapeutic decision-making and to avoid subsequent decisional regret.

Journal Section:
Editor's choice
Keywords:
Complications, Functional outcomes, Prostate cancer , Quality of life, Radical prostatectomy, Urinary incontinence
1.
Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, et al: Cancer incidence and mortality in France over the period 1980–2005. Rev Epidemiol Sante Publique 2008; 56: 159–175.
[PubMed]
https://doi.org/10.1016/j.respe.2008.03.117
2.
Hill C: [The frequency of cancer in France]. Rev Prat 2013; 63: 1106–1110.
[PubMed]
3.
Arnold M, Karim-Kos HE, Coebergh JW, Byrnes G, Antilla A, Ferlay J, et al: Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European cancer observatory. Eur J Cancer 2015; 51: 1164–1187.
[PubMed]
https://doi.org/10.1016/j.ejca.2013.09.002
4.
Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Solo-way C, Soloway MS, et al: A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 2013; 189: 19–25.
[PubMed]
https://doi.org/10.1016/j.juro.2008.11.109
5.
Sathianathen NJ, McGuigan SM, Moon DA: Outcomes of artificial urinary sphincter implantation in the irradiated patient. BJU Int 2014; 113: 636–641.
[PubMed]
https://doi.org/10.1111/bju.12518
6.
Haglind E, Carlsson S, Stranne J, Wallerstedt A, Wilderäng U, Thorsteinsdottir T, et al: Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial. Eur Urol 2015; 68: 216–225.
[PubMed]
https://doi.org/10.1016/j.eururo.2015.02.029
7.
Finkelstein J, Eckersberger E, Sadri H, Taneja SS, Lepor H, Djavan B: Open versus laparoscopic versus robot-assisted laparoscopic prostatectomy: the European and US experience. Rev Urol 2010; 12: 35–43.
[PubMed]
8.
Feldman-Stewart D, Brundage MD, Tong C: Information that affects patients’ treatment choices for early stage prostate cancer: a review. Can J Urol 2011; 18: 5998–6006.
[PubMed]
9.
Enel C, Matte A, Berchi C, Binquet C, Cormier L, Lejeune C: [Prostate cancer: how do patients choose their treatment?]. Bull Cancer 2013; 100: 191–199.
[PubMed]
https://doi.org/10.1684/bdc.2013.1707
10.
Chien CH, Chuang CK, Liu KL, Li CL, Liu HE: Changes in decisional conflict and decisional regret in patients with localised prostate cancer. J Clin Nurs 2013; 23: 1959–1969.
[PubMed]
https://doi.org/10.1111/jocn.12470
11.
Ratcliff CG, Cohen L, Pettaway CA, Parker PA: Treatment regret and quality of life following radical prostatectomy. Support Care Cancer 2013; 21: 3337–3343.
[PubMed]
https://doi.org/10.1007/s00520-013-1906-4
12.
Aning JJ, Wassersug RJ, Goldenberg SL: Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret. Curr Oncol Tor Ont 2012; 19(suppl 3):S37–S44.
[PubMed]
https://doi.org/10.3747/co.19.1287
13.
Holmes JA, Bensen JT, Mohler JL, Song L, Mishel MH, Chen RC: Quality of care received and patient-reported regret in prostate cancer: analysis of a population-based prospective cohort. Cancer 2017; 123: 138–143.
[PubMed]
https://doi.org/10.1002/cncr.30315
14.
Hurwitz LM, Cullen J, Elsamanoudi S, Kim DJ, Hudak J, Colston M, et al: A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic. Urol Oncol 2016; 34: 233.e17–e25.
[PubMed]
https://doi.org/10.1016/j.urolonc.2015.11.014
15.
Stiggelbout AM, Van der Weijden T, De Wit MP, Frosch D, Légaré F, Montori VM, et al: Shared decision making: really putting patients at the centre of healthcare. BMJ 2012; 344:e256.
[PubMed]
https://doi.org/10.1136/bmj.e256
16.
Hacking B, Wallace L, Scott S, Kosmala-Anderson J, Belkora J, McNeill A: Testing the feasibility, acceptability and effectiveness of a ‘decision navigation’ intervention for early stage prostate cancer patients in Scotland – a randomised controlled trial. Psychooncology 2013; 22: 1017–1024.
[PubMed]
https://doi.org/10.1002/pon.3093
17.
Feldman-Stewart D, Tong C, Siemens R, Alibhai S, Pickles T, Robinson J, et al: The impact of explicit values clarification exercises in a patient decision aid emerges after the decision is actually made: evidence from a randomized controlled trial. Med Decis Making 2012; 32: 616–626.
[PubMed]
https://doi.org/10.1177/0272989X11434601
18.
Nan Tol-Geerdink JJ, Leer JW, Wijburg CJ, van Oort IM, Vergunst H, van Lin EJ, et al: Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial. Health Expect 2016; 19: 459–470.
[PubMed]
https://doi.org/10.1111/hex.12369
19.
Violette PD, Agoritsas T, Alexander P, Riikonen J, Santti H, Agarwal A, et al: Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis. CA Cancer J Clin 2015; 65: 239–251.
[PubMed]
https://doi.org/10.3322/caac.21272
© 2017 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2017
You do not currently have access to this content.